Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

I noticed two things from the announcement last week.

"Most clinics require at least two readers to efficiently perform both tests."
This is new information and having 2 readers allows both tests to be administered at the same time. Potentially increasing the number of tests used per day.


"AXIM expects clinics to perform approximately 150 tests per month."
For some reason I thought the original number was 300 tests per month. If the new number is 150 tests per month then Verséa needs to sign up 120 doctor offices for AXIM to become cash-flow positive instead of just 60 locations. Inflation on labor may push this number higher, but let's stay with 120 locations for now.

150 × $10 × 0.70 × 120 = $126,000 per month.
150 tests per month
$10 AXIM receives per test
0.70 percent after manufacturing cost.**
120 locations
$126,000 per month before scientists get paid and rent and bills and other expenses are paid.


** Cost per manufacturing tests was originally projected to be 30% but we don't have any new information after Auer Precision was signed as contract manufacturer.

Verséa Ophthalmics has had a number of announcements of paying customers the last 2 minths. Two announcements mentioned 3 new locations each. Let's estimate 12 to 15 current locations are currently selling our tests.

We are still months away from being cashflow positive at this current pace.

CLIA Waiver approval is still the goal and is required before the current narrative changes much.


Good luck to all.
Not investment advice.